Pregabalin and Orofacial Neuropathic Pain (Pregabalin-Dao)

This study has been terminated.
(difficulty to recruit patients)
Sponsor:
Collaborator:
Pfizer
Information provided by:
University of Toronto
ClinicalTrials.gov Identifier:
NCT00852436
First received: November 6, 2008
Last updated: February 15, 2011
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2011
  Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)